Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
DUPIXENT® (dupilumab) HCP Website
DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 5 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for dupixenthcp.com: 3.162.112.31, 3.162.112.51, 3.162.112.70, 3.162.112.98. Moreover, DNS used with this website include ns1.sanofi-synthelabo.com, ns2.sanofi-synthelabo.com, ns3.sanofi-synthelabo.com, ns4.sanofi-synthelabo.com. Subnet identifier ranges from 3.160.0.0 to 3.163.255.255. Classless Inter-Domain Routing (CIDR) is 3.160.0.0/14. ARIN net type is Reallocated.
Daily Visitors
Last scanned
Domain Age
Global Rank
ns1.sanofi-synthelabo.com
ns2.sanofi-synthelabo.com
ns3.sanofi-synthelabo.com
ns4.sanofi-synthelabo.com
{{value}}
2016-10-13
2024-10-13
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of dupixenthcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-10-13. According to open source data, you can reach the owner at domain.names@sanofi.com but please make sure you have a good reason for unsolicited messages. Their country of residence is France, French Republic.
677K
1.8K
982.3K
N/A
N/A
1K
N/A
N/A
N/A
640
677K
1.8K